← Browse by Condition
Medical Condition

delirium in old age

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for delirium in old age sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — delirium in old age Clinical Trials

How many clinical trials are currently recruiting for delirium in old age?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for delirium in old age, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for delirium in old age?
delirium in old age research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a delirium in old age clinical trial?
Eligibility criteria for delirium in old age trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Penn State University 1 trial
Beth Israel Deaconess Medical Center 1 trial
Charite University, Berlin, Germany 1 trial

Recruiting Clinical Trials

NCT05915377
Recruiting
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Enrollment
1,050 pts
Location
United States
Sponsor
Penn State University
View Trial →
NCT06721819 Phase 3
Recruiting
The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium
Enrollment
406 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT04355195
Recruiting
Quality Contract: Prevention of Postoperative Delirium in the Care of Older Patients (QV-POD-2)
Enrollment
18,100 pts
Location
Germany
Sponsor
Charite University, Berlin, Ge...
View Trial →

Related Conditions

delirium (1) delirium with dementia (1) delirium superimposed on dementia (1) delirium postoperative (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology